These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6915116)

  • 1. [Evaluation of urinary kallikrein assay by using chromogenic peptide substrates (I) (author's transl)].
    Irie A; Kokawa M; Kadono K; Kushiro H; Kodama J
    Rinsho Byori; 1981 Apr; 29(4):419-22. PubMed ID: 6915116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of urinary kallikrein assay using various chromogenic peptide substrates (II)].
    Irie A; Tabuchi A; Takedachi S; Katayama Y; Ito K
    Rinsho Byori; 1984 Nov; 32(11):1242-6. PubMed ID: 6569895
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methods of estimation of urinary kallikrein activity (author's transl)].
    Baudin G; Wahba WK; Mimran A
    Ann Biol Clin (Paris); 1979; 37(1):1-5. PubMed ID: 443606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Inagaki Y; Setsuda Y
    Rinsho Byori; 1979 Dec; 27(12):1121-5. PubMed ID: 541858
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).
    Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA
    Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the determination of prothrombin with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Feb; 28(2):153-7. PubMed ID: 7366016
    [No Abstract]   [Full Text] [Related]  

  • 7. [A clinical study on urinary kallikrein in patients with renal diseases (author's transl)].
    Numahata H
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):203-17. PubMed ID: 470231
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of prothrombin assay using chromogenic peptide substrates (author's transl)].
    Akiyama Y; Hibiya Y; Nakatake T; Kazama M
    Rinsho Byori; 1980 Nov; 28(11):1131-5. PubMed ID: 7241816
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
    Asai K; Takagi A; Otsubo M
    Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
    [No Abstract]   [Full Text] [Related]  

  • 10. A new assay for urinary kallikrein.
    Morris DH; Stewart JM
    Adv Biosci; 1978 Jul; 17():139-43. PubMed ID: 755690
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the determination of plasma prekallikrein with chromogenic peptide substrate (author's transl)].
    Nakamura S; Takizawa N; Nakanishi K; Igarashi M
    Rinsho Byori; 1980 Jul; 28(7):670-4. PubMed ID: 6906394
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assay method of plasma plasminogen by means of a synthetic fluorogenic peptide substrate (3104-V) (author's transl)].
    Suzuki K; Nishioka J; Hashimoto S
    Rinsho Byori; 1980 Aug; 28(8):804-7. PubMed ID: 7206258
    [No Abstract]   [Full Text] [Related]  

  • 13. A kinetic assay for human urinary kallikrein determination.
    Meani A; Fabris C; Vianello D; Piccoli A; Del Favero G; Farini R
    Enzyme; 1985; 33(2):89-93. PubMed ID: 3847347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on measurement of human plasma kallikrein system (author's transl)].
    Chiba Y; Haneda Y; Segawa M; Seino Y; Okamoto K; Yoshida Y
    Rinsho Ketsueki; 1978 Mar; 19(3):214-20. PubMed ID: 702807
    [No Abstract]   [Full Text] [Related]  

  • 15. [Assay of urinary kallikrein and its significance].
    Miyashita A
    Rinsho Byori; 1982 Mar; Suppl 49():130-5. PubMed ID: 7050463
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary kallikrein activity is increased during the first few weeks of exercise training in essential hypertension.
    Miura S; Tashiro E; Sakai T; Koga M; Kinoshita A; Sasaguri M; Ideishi M; Ikeda M; Tanaka H; Shindo M
    J Hypertens; 1994 Jul; 12(7):815-23. PubMed ID: 7963511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein in postobstructive diuresis.
    Lawton W; O'Connor G; Nelson J; Fitz A
    Invest Urol; 1980 Jan; 17(4):320-3. PubMed ID: 7351365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary kallikrein excretion and plasma atrial natriuretic peptide in human salt-sensitive hypertension.
    Ferri C; Bellini C; Carlomagno A; Baldoncini R; De Siati L; Perrone A; Santucci A; Balsano F
    J Hypertens Suppl; 1993 Dec; 11(5):S212-3. PubMed ID: 8158350
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary kallikrein excretion in renal transplant patients.
    Brouhard BH; Cunningham RJ; Berger M; Petrusick TW; Travis LB
    Clin Nephrol; 1982 May; 17(5):241-6. PubMed ID: 7047034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.